Novavax’s Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Received Authorization in the EU
On Oct. 9, 2024, Novavax announced that the European Commission had granted Marketing Authorization for Novavax’s updated 2024-2025…
On Oct. 9, 2024, Novavax announced that the European Commission had granted Marketing Authorization for Novavax’s updated 2024-2025…
On Oct. 8, 2024, the Pan American Health Organization (PAHO) announced an epidemiological alert and urged countries in…
On Oct. 5, 2024, the Sabin Vaccine Institute announced it had provided its investigational Marburg vaccine to Rwanda…
On Oct. 4, 2024, researchers from Oxford university announced they had been awarded funding from Cancer Research UK…
On Oct. 4, 2024, the World Health Organization (WHO) announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine…
On Oct. 4, 2024, the Centers for Disease Control and Prevention (CDC) published data that showed older adults…
On Oct. 24, 2024, GSK announced an $800 million investment that will bring state-of-the-art drug substance manufacturing and…
On Oct. 4, 2024, scientists from the the University of Chile announced they had developed an injection that…
On Oct. 3, 2024, two dairy workers in California were infected with bird flu, the 15th and 16th…
On Oct. 3, 2024, the World Health Organization (WHO) launched the Global Strategic Preparedness, Readiness and Response Plan…
On Sept. 28, 2024, the World Health Organization (WHO) announced that Rwandan health authorities were intensifying outbreak control…
On Sept. 27, 2024, a study that evaluated the structural and functional connectivity correlates of fatigue in post-COVID…
On Sept. 27, 2024, the World Health Organization (WHO) announced the recommendations for the viral composition of influenza…
On Sept. 25, 2024, drug-resistant pathogens could jeopardise the food supply of over two billion people and increase…
On Sept. 25, 2024, U.S. healthcare workers receiving additional vaccine doses during the Omicron period (December 2021 to…
On Sept. 24, 2024, U.S. President Joe Biden announced the donation of 1 million mpox vaccine doses and…
On Sept. 23, 2024, researchers from Columbia University reported that a study of Children born during the first…
On Sept. 20, 2024, the U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is…
On Sept. 19, 2024, Oxitec announced it had launched Sparks™, a new commercial platform to accelerate the global…
On Sept. 19, 2024, the European Medical Agency (EMA) announced it had recommended extending the indication of the…
On Sept. 19, 2024, a U.S. population-based birth cohort study was released that showed that 53.4% of babies…
On Sept. 19, 2024, an international team of researchers announced a study that genetically traced the epicenter of…
On Sep. 13. 2024, Novavax announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to…
On Sept. 13, 2024, CSL Seqirus and sa-mRNA pioneer Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor…
On Sept. 12, 2024, the Finnish Institute for Health and Welfare (THL) reported that Poliovirus had been found…
On Sept. 11, 2024, an international team of scientists led by the Leibniz Institute on Aging announced they…
On Sep. 11, 2024, researchers at UTHealth Houston and Baylor College of Medicine reported that Avian influenza A(H5N1)…
On Sep. 9, 2024, Santo Fortunato, a professor at Luddy School of Informatics, reported that an international research…
On Sep. 6, 2024, the Centers for Disease Control and Prevention (CDC) confirmed a human case of avian…
On Sep. 4, 2024, researcher led by the Centers for Disease Control and Prevention (CDC) and Vanderbilt University…